, Hong Kong

Hong Kong insurance sector taps on rattled Chinese market

New business premiums from Mainland clients hit $11.8b in Q1.

Reuters reports that Hong Kong insurers are steadily tapping on the Chinese affluent who in turn are seeking safe haven in the nearby SAR from yuan depreciation and healthcare safety woes in their home turf.

New business premiums from mainland clients hit $11.8b (US$1.50b) in Q1, with 95% spent on medical or protective products, according to data from the Hong Kong Insurance Authority.

Insurance savings products denominated in Hong Kong or US dollars are seen as attractive investments for hedging against the weakening yuan which has dropped more than 6% since mid June.

AIA Group, a Hong Kong-listed insurer, also reported a 20% rise in new business in Q1 on the back of higher demand for insurance products in mainland China and Hong Kong.

Also read: Hong Kong poised for insurtech growth in 2018

Hong Kong has often emerged as a safe haven for Chinese residents rattled by environmental and health safety concerns back home with the revelation that Mainland biotech firm Changsheng Bio-technology Co Ltd falsifying the data for its rabies vaccine the latest in a series of scandals prompting the residents to flock to the nearby SAR.

Here’s more from Reuters

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.